I do not know that actual approval of either the c
Post# of 15624
(Total Views: 395)
Posted On: 02/22/2019 2:51:38 PM
Re: Letitride1027 #14253
I do not know that actual approval of either the cream or the sublingual tablet can come out of the next trial they've discussed. It sounds like they are considering proving the safety, demonstrating some degree of efficacy, and putting it on the market without the formal approval of any Govt. agency. This is a path they've previously alluded to, and it would be legal to do so wherever cannabis based products are legal.
I'm frankly confused by some of the language, it sounds like they're saying that after a short trial of the sublingual tablet it could be substituted for an approved product. The only approved product I'm aware of should have patent coverage that would prevent such an action, even if our product essentially did the same thing. I understand he's saying this is a second generation of the sublingual tablet, but if it's our second generation, the first generation was never put through trials. If it's being called second generation of the approved product, I question how they can get around whatever protection exists for that product.
I believe many of the questions would be answered if the trials being scheduled were in the clinical trials database, but if the company continues to play all their cards close to the vest, it leaves us with many unanswered questions that I believe keep the share price down.
If in fact the sublingual tablet could be distributed out of Israel after the short trial that the company referred to, their would be a question of where it could be marketed. I don't know the specifics, but I believe in many of the States here in the U.S. cannabis based products must be made in that State. I don't know that this applies in many countries where it's legal, but year's ago the company had a partnership with a company that intended to establish distribution and sales throughout the U.S. I believe the partnership was ended because they clearly couldn't do what they intended to.
Frankly the U.S. market is still a mess, and probably will remain so until the Federal Govt acts to legalize cannabis in some way. Here in California the L.A. Times just had an article on how licensed cannabis operations were being hurt by those who are growing and selling unlicensed products. As a consumer, I don't know which store is licensed, and what isn't, especially if the Govt. is allowing unlicensed sites to openly operate which was alleged in the article.
I frankly have a few cannabis based stocks, none of them are doing very well, but I still believe they have the potential to. I still believe it's far to early to say who'll succeed and who'll fail, but clearly their have been some that have done well. I suspect that over the next decade many of these companies will merge, some will fail, but some will succeed beyond expectations. If the Govt. were to totally legalize cannabis so that products could be sold in any drug store, etc all the stores currently selling products would probably disappear. I'm not saying this will happen in the next decade, but eventually I believe most products will be as easy to purchase as alcohol based products. I suspect that within 5 miles of my house there are at least a dozen cannabis based stores, I cannot say if all are legal or not, but they appear to be and clearly they're operating openly. I have no idea how prosperous the various stores are, but Statewise sales don't appear to be as high as anticipated.
Gary
I'm frankly confused by some of the language, it sounds like they're saying that after a short trial of the sublingual tablet it could be substituted for an approved product. The only approved product I'm aware of should have patent coverage that would prevent such an action, even if our product essentially did the same thing. I understand he's saying this is a second generation of the sublingual tablet, but if it's our second generation, the first generation was never put through trials. If it's being called second generation of the approved product, I question how they can get around whatever protection exists for that product.
I believe many of the questions would be answered if the trials being scheduled were in the clinical trials database, but if the company continues to play all their cards close to the vest, it leaves us with many unanswered questions that I believe keep the share price down.
If in fact the sublingual tablet could be distributed out of Israel after the short trial that the company referred to, their would be a question of where it could be marketed. I don't know the specifics, but I believe in many of the States here in the U.S. cannabis based products must be made in that State. I don't know that this applies in many countries where it's legal, but year's ago the company had a partnership with a company that intended to establish distribution and sales throughout the U.S. I believe the partnership was ended because they clearly couldn't do what they intended to.
Frankly the U.S. market is still a mess, and probably will remain so until the Federal Govt acts to legalize cannabis in some way. Here in California the L.A. Times just had an article on how licensed cannabis operations were being hurt by those who are growing and selling unlicensed products. As a consumer, I don't know which store is licensed, and what isn't, especially if the Govt. is allowing unlicensed sites to openly operate which was alleged in the article.
I frankly have a few cannabis based stocks, none of them are doing very well, but I still believe they have the potential to. I still believe it's far to early to say who'll succeed and who'll fail, but clearly their have been some that have done well. I suspect that over the next decade many of these companies will merge, some will fail, but some will succeed beyond expectations. If the Govt. were to totally legalize cannabis so that products could be sold in any drug store, etc all the stores currently selling products would probably disappear. I'm not saying this will happen in the next decade, but eventually I believe most products will be as easy to purchase as alcohol based products. I suspect that within 5 miles of my house there are at least a dozen cannabis based stores, I cannot say if all are legal or not, but they appear to be and clearly they're operating openly. I have no idea how prosperous the various stores are, but Statewise sales don't appear to be as high as anticipated.
Gary
(0)
(0)